Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 739.50 GBp
Change Today +19.00 / 2.64%
Volume 205.5K
CLIN On Other Exchanges
As of 11:35 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Ian James Nicholson B.Sc., MBA

Non-Executive Director, Chairman of Remuneration Committee, Member of Nomination Committee and Member of Audit & Risk Committee, Clinigen Group Plc
AgeTotal Calculated CompensationThis person is connected to 26 board members in 4 different organizations across 8 different industries.

See Board Relationships


Mr. Ian James Nicholson, B.Sc., MBA, has been the Chief Business Officer at NeRRe Therapeutics Ltd since March 2014. Mr. Nicholson has been the Chief Executive Officer of F2G Ltd. since March 2013. Mr. Nicholson has been an Operating Partner at Advent Venture Partners since December 17, 2012. He is employed as a part of the life sciences team. He served as the Chief Executive Officer of Chroma Therapeutics Ltd. from 2004 to July 2012. He joined Chroma in September 2004. ...

Read Full Background

Corporate Headquarters*

Pitcairn House
Burton-on-Trent, Staffordshire DE14 2WW

United Kingdom

Phone: 44 12 8349 4340
Fax: --

Board Members Memberships*

Non-Executive Chairman, Member of Remuneration Committee and Member of Nomination Committee
Non-Executive Director, Chairman of Corporate Responsibility (CR) Committee, Member of Remuneration Committee, Member of Nomination Committee and Member of Audit Committee
Non-Executive Director, Chairman of Remuneration Committee, Member of Nomination Committee and Member of Audit & Risk Committee
Chief Executive Officer and Executive Director


Boston University
University College London

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLIN:LN 739.50 GBp +19.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLINIGEN GROUP PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at